Rachel Jenkins, BSc, Taylor & Francis; Dawn Nicewarner, PhD, CMPP, Organon; Steve Palmisano, BSc, The Lockwood Group; Kelly Soady, PhD, CMPP, Oxford PharmaGenesis. Email your questions and comments on this article to TheMAP@ismpp.org. What Does Accessibility...
Jennifer Ghith, MS, MBA, GlaxoSmithKline; Matt Lewis, MPA, LLMental; Bob Schijvenaars, PhD, Digital Science; Monica Mody, PhD, Madrigal Pharmaceuticals; Andy Shepherd, PhD, CMPP, Envision Medical Communications; Valerie Moss, PhD, CMPP, Prime; Gary Lyons, Coronado...
Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
Lisa M. Baker, HEORpubs, USA; Tina K. Schlafly, Corcept Therapeutics, USA; Meredith Whitaker, Alphabet Health, USA Email your questions and comments on this article to TheMAP@ismpp.org. An Overview for New and Transitioning Professionals Medical communications...
The wonderful spirit of collaboration among the ISMPP community was alive and thriving at the 21st Annual Meeting of ISMPP, May 12-14, 2025, in Washington, DC. The theme for the 21st Annual Meeting was Diversity and Innovation: In Concert. In today’s rapidly evolving...
